Volunteers sought for study
Nobel Laureate Professor Barry Marshall is seeking volunteers to take part in a potentially ground-breaking study.
The study aims to find out if people develop immunity against a common stomach infection called Helicobacter pylori or H. pylori.
Marshall and colleagues at Sir Charles Gairdner Hospital believe H. pylori could be used to create a new super-vaccine if they can prove people never become immune to it.
They believe the bacterium could be used to deliver vaccines against multiple strains of viruses such as influenza and bird-flu and possibly even HIV or malaria.
"There is anecdotal evidence to suggest people do not develop immunity against H. pylori. However, we need to conduct this study to determine conclusively if this is really the case," Marshall, a consultant gastroenterologist at Sir Charles Gairdner Hospital, said.
"If we can demonstrate that the immune system cannot protect against H. pylori, then we may be able to use this bacterium to deliver multiple vaccines into the body. These vaccines could protect against many strains of virus. It would revolutionise the fight against viruses and microorganisms such as influenza, HIV and malaria, which are constantly evolving."
Approximately one in four people carries H. pylori. Most carriers contract the bacterium in childhood and the vast majority suffer no ill effects during their lives. The infection can usually be treated with conventional antibiotics.
In some cases, H. pylori can trigger stomach ulcers. In 2005, Marshall and Dr Robin Warren were awarded the Nobel Prize for Medicine when they proved that the bacterium rather than stress or spicy food caused most stomach ulcers.
Anyone between the age of 18 and 65 interested in volunteering to take part in this study can obtain further information by phoning 9346 4725 or by emailing rosalind.stott@health.wa.gov.au.
A simple finger prick can be used to diagnose Alzheimer's
A new study is paving the way for a more accessible method of Alzheimer's testing, requiring...
Experimental blood test detects early-stage pancreatic cancer
The new test works by detecting two sugars — CA199.STRA and CA19-9 — that are...
Biomarkers for dementia vary with time of day
Biomarkers used to diagnose Alzheimer's, including a promising marker for early diagnosis of...